FUJIFILM Wako Chemicals U.S.A. CorporationMay 10, 2024

FDA 483 - FUJIFILM Wako Chemicals U.S.A. Corporation - May 10, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore FUJIFILM Wako Chemicals U.S.A. Corporation

Record Details

An FDA inspection of FUJIFILM Wako Chemicals U.S.A. Corporation in Richmond, VA, revealed significant deficiencies in their manufacturing processes for IVD products. Observations included inadequate control and monitoring of production, failures in equipment calibration and maintenance, and issues with device history record documentation. These findings indicate a lack of adherence to established quality system procedures.

Company: FUJIFILM Wako Chemicals U.S.A. Corporation
Inspection Date: May 10, 2024
Product Type: Device
Office: Office of Regulatory Affairs
People: Edward A. Brunt (FDA_PERSONNEL)
Nisha C. Patel
Christian D. Lynch (investigator)

Open in Dashboard

ID · 42037290-7bd3-4be1-bb50-37bea011030d